Search hospitals

>

California

>

Stanford

Stanford University School of Medicine

Claim this profile

Stanford, California 94305

Global Leader in Breast Cancer

Global Leader in Cancer

Conducts research for Leukemia

Conducts research for Non-Hodgkin's Lymphoma

Conducts research for Obesity

831 reported clinical trials

40 medical researchers

Photo of Stanford University School of Medicine in StanfordPhoto of Stanford University School of Medicine in StanfordPhoto of Stanford University School of Medicine in Stanford

Summary

Stanford University School of Medicine is a medical facility located in Stanford, California. This center is recognized for care of Breast Cancer, Cancer, Leukemia, Non-Hodgkin's Lymphoma, Obesity and other specialties. Stanford University School of Medicine is involved with conducting 831 clinical trials across 796 conditions. There are 40 research doctors associated with this hospital, such as Robert Lowsky, MD, Christopher Chen, Antonio Hardan, MD, and David Miklos, MD, PhD.

Area of expertise

1

Breast Cancer

Global Leader

Stanford University School of Medicine has run 50 trials for Breast Cancer. Some of their research focus areas include:

Stage IV
2

Cancer

Global Leader

Stanford University School of Medicine has run 49 trials for Cancer. Some of their research focus areas include:

Stage IV
BCL2 positive
t(11;14) positive

Top PIs

Clinical Trials running at Stanford University School of Medicine

Autism Spectrum Disorder

Cancer

Chronic Lymphocytic Leukemia

Breast Cancer

Head and Neck Cancers

Autism

Non-Hodgkin's Lymphoma

Locked-In Syndrome

Brain Stem Stroke

Spinal Cord Injury

Image of trial facility.

Early Intervention Program

for Autism Spectrum Disorder

This trial is testing a program where children spend time each week in a special preschool or at home doing activities. The goal is to help children with developmental disorders, like Autism, improve their social communication skills. By engaging in these structured activities, the children can learn to communicate and interact better.

Recruiting

1 award

N/A

6 criteria

Image of trial facility.

Pivotal Response Treatment

for Autism

The aim of this clinical trial is to compare the efficacy of a 16-week center-based Pivotal Response Treatment (PRT-C) versus home-based Pivotal Response Treatment (PRT-H) in targeting social communication deficits in young children with autism spectrum disorder (ASD) with significant language delay. The two groups will also be compared to a control group that consists of children who are receiving treatment as usual (TAU).

Recruiting

1 award

N/A

Image of trial facility.

Esomeprazole

for Autism

Autism is a pervasive developmental disorder characterized by core deficits in social behavior and communication and the presence of repetitive/stereotyped behaviors. The objective of the study is to evaluate the efficacy of Esomeprazole as a treatment for social communication deficits in children with Autism Spectrum Disorder (ASD). This prospective 12 week open-label study will invite 25 children with ASD between the ages of 2 and 6 years of age to participate.

Recruiting

1 award

Phase 2

3 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Stanford University School of Medicine?

Where is Stanford University School of Medicine located?

Who should I call to ask about financial aid or insurance network?

What insurance does Stanford University School of Medicine accept?

What awards or recognition has Stanford University School of Medicine received?